Cleared Traditional

K905020 - SLIDEX STREPTO-KIT

K905020 is the FDA 510(k) clearance for SLIDEX STREPTO-KIT by Vitek Systems, Inc.. It is a Class 1 Microbiology device (product code GTY) cleared through the Traditional 510(k) pathway after a 82-day FDA review.

K905020 · Vitek Systems, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1991
Decision
82d
Days
Class 1
Risk

K905020 is an FDA 510(k) clearance for the SLIDEX STREPTO-KIT. Classified as Antigens, All Groups, Streptococcus Spp. (product code GTY), Class I - General Controls.

Submitted by Vitek Systems, Inc. (Hazelwood, US). The FDA issued a Cleared decision on January 28, 1991 after a review of 82 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3740 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Vitek Systems, Inc. devices

Submission Details

510(k) Number K905020 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 07, 1990
Decision Date January 28, 1991
Days to Decision 82 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d faster than avg
Panel avg: 102d · This submission: 82d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTY Antigens, All Groups, Streptococcus Spp.
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3740
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTY Antigens, All Groups, Streptococcus Spp.

All 28
Devices cleared under the same product code (GTY) and FDA review panel - the closest regulatory comparables to K905020.
QUICKVUE IN-LINE ONE-STEP STREP A CONTROL SWABS (POSITIVE & NEGATIVE SWAB SPECIMENS)
K945080 · Quidel Corp. · Feb 1995
BIOSTARS STREP A OIA -- MODIFICATION
K922765 · Biosearch Medical Products, Inc. · Aug 1992
ABBOTT STREP A CONTROLS
K922490 · Abbott Laboratories · Jul 1992
KODAK SURECELL(TM) STREP A CONTROL FLUID SET
K904589 · Eastman Kodak Company · Jan 1991
ICON STREP B IMMUNOENZYMETRIC ASSAY
K902991 · Hybritech, Inc. · Oct 1990
ABBOTT TESTPACK(TM) STREP A POSITIVE CONTROL
K864752 · Abbott Laboratories · Feb 1987